GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shan Dong Kexing Bioproducts Co Ltd (SHSE:688136) » Definitions » Equity-to-Asset

Shan Dong Kexing Bioproducts Co (SHSE:688136) Equity-to-Asset : 0.53 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Shan Dong Kexing Bioproducts Co Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Shan Dong Kexing Bioproducts Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥1,620 Mil. Shan Dong Kexing Bioproducts Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,064 Mil. Therefore, Shan Dong Kexing Bioproducts Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 was 0.53.

The historical rank and industry rank for Shan Dong Kexing Bioproducts Co's Equity-to-Asset or its related term are showing as below:

SHSE:688136' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.29   Med: 0.59   Max: 0.81
Current: 0.53

During the past 7 years, the highest Equity to Asset Ratio of Shan Dong Kexing Bioproducts Co was 0.81. The lowest was 0.29. And the median was 0.59.

SHSE:688136's Equity-to-Asset is ranked worse than
62.16% of 1559 companies
in the Biotechnology industry
Industry Median: 0.67 vs SHSE:688136: 0.53

Shan Dong Kexing Bioproducts Co Equity-to-Asset Historical Data

The historical data trend for Shan Dong Kexing Bioproducts Co's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shan Dong Kexing Bioproducts Co Equity-to-Asset Chart

Shan Dong Kexing Bioproducts Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Equity-to-Asset
Get a 7-Day Free Trial 0.59 0.76 0.68 0.57 0.54

Shan Dong Kexing Bioproducts Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.55 0.55 0.54 0.53

Competitive Comparison of Shan Dong Kexing Bioproducts Co's Equity-to-Asset

For the Biotechnology subindustry, Shan Dong Kexing Bioproducts Co's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shan Dong Kexing Bioproducts Co's Equity-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shan Dong Kexing Bioproducts Co's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Shan Dong Kexing Bioproducts Co's Equity-to-Asset falls into.



Shan Dong Kexing Bioproducts Co Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Shan Dong Kexing Bioproducts Co's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Equity to Asset (A: Dec. 2023 )=Total Stockholders Equity/Total Assets
=1626.021/3031.093
=0.54

Shan Dong Kexing Bioproducts Co's Equity to Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

Equity to Asset (Q: Mar. 2024 )=Total Stockholders Equity/Total Assets
=1620.012/3063.871
=0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shan Dong Kexing Bioproducts Co  (SHSE:688136) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Shan Dong Kexing Bioproducts Co Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Shan Dong Kexing Bioproducts Co's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Shan Dong Kexing Bioproducts Co (SHSE:688136) Business Description

Traded in Other Exchanges
N/A
Address
No. 2666, Chuangye Road, Mingshui Development Zone, Zhangqiu District, Shandong Province, Jinan, CHN, 250200
Shan Dong Kexing Bioproducts Co Ltd formerly Kexing Biopharmaceutical Co Ltd is an innovative biopharmaceutical company. It is engaged in the production and sales of recombinant protein drugs and probiotics. The company use the drugs in the fields of antiviral, hematology, tumor and immunity, and degenerative diseases.
Executives
Wang Xiao Qin Directors, senior managers
Cui Ning Directors, senior managers
Ma Hong Jie senior management
Shao Ke senior management
Deng Xue Qin Director
Zhao Yan Qing Directors, senior managers

Shan Dong Kexing Bioproducts Co (SHSE:688136) Headlines

No Headlines